Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

The Defense Health Agency (DHA) has issued RFQ HT9402‑26‑Q‑9103 seeking Uniform Formulary (UF) Blanket Purchase Agreement (BPA) and/or Additional Discount Program (ADP) price quotes for pharmaceutical agents identified for inclusion on the DoD Uniform Formulary. Offerors must submit signed, electronic quotes for each strength, dosage form, and package size (including alpha‑numeric size information) identified by NDC, with unit prices shown to four decimal places and package prices calculated accordingly. Prices must be equal to or lower than the current Federal Supply Schedule (FSS), “Big 4,” or National Contract (NC) rates as verified on the VA NAC Search Tool, and must remain valid for 180 days. Companies must also agree to work with the DoD Prime Vendor Program for both MTF and mail‑order channels and to open a limited distribution channel to Accredo for TRICARE mail‑order (DOD‑only). A Manufacturer Quote Submission Checklist must be completed, confirming contract number, company name, price parity across package sizes, and inclusion of all required package sizes. In addition to pricing, respondents must provide clinical advantage information for any newly approved drug and answer specific comparative questions via email to the RFQ point of contact. The solicitation includes three pricing‑concession windows prior to the quarterly DoD Pharmacy & Therapeutics Committee meeting, where drugs will be evaluated for Tier 1‑4/Not Covered status based on clinical and cost effectiveness. The contract may be terminated by either party with 120 days’ written notice. All submissions are to be sent electronically to the designated RFQ POC as outlined in Part 2.3 of the solicitation.

Notice ID

7f828f4d50e040c5bcbcc894c50354fd

Solicitation Number

HT9402-26-Q-9103

NAICS Code

325412

Classification Code

6505